R Hehlmann|T Hunt - JoVE Visualize

Showing results (351-360 of 719) with videos related to

Pageof 72

Sort By:

Veterinaria Italiana|April 27, 2010

Temporal activity of biting midges (Diptera: Ceratopogonidae) on cattle near Darwin, Northern Territory, AustraliaG A Bellis, L F Melville, N T Hunt, et al.

Molecular Diagnosis & Therapy|October 17, 2022

Epidermolysis Bullosa: A Review of the Tissue-Engineered Skin Substitutes Used to Treat WoundsAlex du Rand, John M T Hunt, Vaughan Feisst, et al.

Journal of Molecular Evolution|January 1, 1985

New perspectives on bacterial ferredoxin evolutionD G George, L T Hunt, L S Yeh, et al.

Blood|September 25, 1999

Mutator phenotype in human hematopoietic neoplasms and its association with deletions disabling DNA repair genes and bcl-2 rearrangementsS Indraccolo, S Minuzzo, L Nicoletti, et al.

Leukemia|September 30, 2015

Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemiaM Pfirrmann, M Baccarani, S Saussele, et al.

Leukemia|January 1, 1992

Chronic myelogenous leukemia: recent developments in prognostic evaluation and chemotherapy. The German CML Study GroupR Hehlmann, H Heimpel, M Griesshammer, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000

Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapyM Schmidt, A Hochhaus, S A König-Merediz, et al.

Onkologie|February 1, 1991

[Multicenter prospective controlled study of therapy of chronic myeloid leukemia. Comparison of busulfan, hydroxyurea and interferon alpha (April 1990 status)]R Hehlmann, H Heimpel, B Heinze, et al.

Leukemia|August 28, 2009

Harmonization of molecular monitoring of CML therapy in EuropeM C Müller, N C P Cross, P Erben, et al.

Genes to Cells : Devoted to Molecular & Cellular Mechanisms|May 15, 1998

A measure of the mitotic index: studies of the abundance and half-life of p34cdc2 in cultured cells and normal and neoplastic tissuesJ V Gannon, A Nebreda, N M Goodger, et al.

Pageof 72

Showing results (351-360 of 719) with videos related to

Sort By:

Pageof 72

Veterinaria Italiana|April 27, 2010

Temporal activity of biting midges (Diptera: Ceratopogonidae) on cattle near Darwin, Northern Territory, AustraliaG A Bellis, L F Melville, N T Hunt, et al.

Molecular Diagnosis & Therapy|October 17, 2022

Epidermolysis Bullosa: A Review of the Tissue-Engineered Skin Substitutes Used to Treat WoundsAlex du Rand, John M T Hunt, Vaughan Feisst, et al.

Journal of Molecular Evolution|January 1, 1985

New perspectives on bacterial ferredoxin evolutionD G George, L T Hunt, L S Yeh, et al.

Blood|September 25, 1999

Mutator phenotype in human hematopoietic neoplasms and its association with deletions disabling DNA repair genes and bcl-2 rearrangementsS Indraccolo, S Minuzzo, L Nicoletti, et al.

Leukemia|September 30, 2015

Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemiaM Pfirrmann, M Baccarani, S Saussele, et al.

Leukemia|January 1, 1992

Chronic myelogenous leukemia: recent developments in prognostic evaluation and chemotherapy. The German CML Study GroupR Hehlmann, H Heimpel, M Griesshammer, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000

Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapyM Schmidt, A Hochhaus, S A König-Merediz, et al.

Onkologie|February 1, 1991

[Multicenter prospective controlled study of therapy of chronic myeloid leukemia. Comparison of busulfan, hydroxyurea and interferon alpha (April 1990 status)]R Hehlmann, H Heimpel, B Heinze, et al.

Leukemia|August 28, 2009

Harmonization of molecular monitoring of CML therapy in EuropeM C Müller, N C P Cross, P Erben, et al.

Genes to Cells : Devoted to Molecular & Cellular Mechanisms|May 15, 1998

A measure of the mitotic index: studies of the abundance and half-life of p34cdc2 in cultured cells and normal and neoplastic tissuesJ V Gannon, A Nebreda, N M Goodger, et al.

Pageof 72